Currently out of the existing stock ratings of Stacy Ku, 19 are a BUY (100%).

Stacy Ku

Work Performance Price Targets & Ratings Chart

Analyst Stacy Ku, currently employed at TD COWEN, carries an average stock price target met ratio of 30.56% that have a potential upside of 20.85% achieved within 94 days.

Stacy Ku’s has documented 39 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AUPH, Aurinia Pharmaceuticals at 21-Oct-2026.

Wall Street Analyst Stacy Ku

Analyst best performing recommendations are on VRCA (VERRICA PHARMACEUTICALS).
The best stock recommendation documented was for VRCA (VERRICA PHARMACEUTICALS) at 10/21/2024. The price target of $10 was fulfilled within 15 days with a profit of $5.7 (36.31%) receiving and performance score of 24.2.

Average potential price target upside

ATXS Astria Therapeutics AUPH Aurinia Pharmaceuticals BCRX BioCryst Pharmaceuticals KALV Kalvista Pharmaceuticals LENZ LENZ Therapeutics SUPN Supernus Pharmaceuticals VRCA Verrica Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-Apr-2025

11 months 23 days ago
(12-Nov-2025)

0/2 (0%)

$42.13 (613.25%)

Buy Since 01-Jul-2022

$20

1 years 19 days ago
(16-Oct-2025)

2/23 (8.7%)

$11.55 (136.69%)

329

Buy Since 02-Sep-2021

$13

$0.42 (3.34%)

$28

1 years 20 days ago
(15-Oct-2025)

3/11 (27.27%)

$1.08 (9.06%)

466

Buy Since 31-Jan-2025

$26

1 years 20 days ago
(15-Oct-2025)

0/4 (0%)

$19.13 (278.46%)

Buy Since 12-May-2017

$28

1 years 21 days ago
(14-Oct-2025)

0/12 (0%)

$17.91 (177.50%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Stacy Ku most bullish on?

Potential upside of $1.35 has been obtained for AUPH (AURINIA PHARMACEUTICALS)

What Year was the first public recommendation made by Stacy Ku?

On 2023
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?